Tubulo-vesicular structure localization signals

    公开(公告)号:US08993742B2

    公开(公告)日:2015-03-31

    申请号:US12973624

    申请日:2010-12-20

    CPC classification number: C07K14/47

    Abstract: The invention relates to polarized cell tubulo-vesicular structure localization signals. The localization signals are utilized as research tools or are linked to polypeptides of interest or therapeutic molecules. Disclosed are methods of making and using polypeptides and modified polypeptides as signals to localize therapeutics, experimental compounds, peptides, proteins and/or other macromolecules to the tubulo-vesicular structures of polarized cells. The polypeptides of the invention optionally include linkage to reporters, epitopes and/or other experimental or therapeutic molecules. The invention also encompasses polynucleotides encoding the localization signals and vectors comprising these polynucleotides.

    mTOR ligands and polynucleotides encoding mTOR ligands
    2.
    发明授权
    mTOR ligands and polynucleotides encoding mTOR ligands 有权
    mTOR配体和编码mTOR配体的多核苷酸

    公开(公告)号:US08679784B2

    公开(公告)日:2014-03-25

    申请号:US13491315

    申请日:2012-06-07

    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.

    Abstract translation: 本发明涉及激酶配体和聚合配体。 特别地,本发明涉及调节mTOR活性的配体,均聚配体和杂多糖配体。 配体和聚合物配体被用作研究工具或治疗剂。 本发明包括配体和聚合配体与细胞定位信号,表位标签和/或报告子的连接。 本发明还包括编码配体和聚合配体的多核苷酸。

    ERK ligands and polynucleotides encoding ERK ligands
    3.
    发明申请
    ERK ligands and polynucleotides encoding ERK ligands 有权
    ERK配体和编码ERK配体的多核苷酸

    公开(公告)号:US20090186379A1

    公开(公告)日:2009-07-23

    申请号:US11983235

    申请日:2007-11-08

    Abstract: The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.

    Abstract translation: 本发明涉及激酶抑制剂配体和聚合配体。 特别地,本发明涉及调节ERK活性的配体和聚合配体。 配体和聚合物配体被用作研究工具或治疗剂。 本发明包括配体和聚合配体与细胞定位信号,表位标签和/或报告子的连接。 本发明还包括编码配体和聚合配体的多核苷酸。

    Glycogen synthase kinase heteropolyligand polypeptide
    8.
    发明授权
    Glycogen synthase kinase heteropolyligand polypeptide 有权
    糖原合酶激酶杂多肽多肽

    公开(公告)号:US08729225B2

    公开(公告)日:2014-05-20

    申请号:US11937685

    申请日:2007-11-09

    CPC classification number: C12N9/1051 C07K14/47 C12N15/85

    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.

    Abstract translation: 本发明涉及激酶配体和聚合配体。 特别地,本发明涉及调节GSK3活性的配体和聚合配体。 配体和聚合物配体被用作研究工具或治疗剂。 本发明包括配体和聚合配体与细胞定位信号,表位标签和/或报告子的连接。 本发明还包括编码配体和聚合配体的多核苷酸。

    Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
    10.
    发明授权
    Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide 有权
    细胞外信号调节激酶(ERK)杂多肽多肽

    公开(公告)号:US08283445B2

    公开(公告)日:2012-10-09

    申请号:US11983235

    申请日:2007-11-08

    Abstract: The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.

    Abstract translation: 本发明涉及激酶抑制剂配体和聚合配体。 特别地,本发明涉及调节ERK活性的配体和聚合配体。 配体和聚合物配体被用作研究工具或治疗剂。 本发明包括配体和聚合配体与细胞定位信号,表位标签和/或报告子的连接。 本发明还包括编码配体和聚合配体的多核苷酸。

Patent Agency Ranking